CS Diagnostics Corp. (CSDX)

OTCMKTS · Delayed Price · Currency is USD
0.4000
-0.0165 (-3.95%)
Apr 4, 2025, 4:00 PM EST
132.42%
Market Cap 54.94M
Revenue (ttm) n/a
Net Income (ttm) -341.61K
Shares Out 137.34M
EPS (ttm) -3.54
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 23,234
Average Volume 31,416
Open 0.2438
Previous Close 0.4165
Day's Range 0.2438 - 0.4380
52-Week Range 0.1360 - 5.6400
Beta -20.31
RSI 47.18
Earnings Date n/a

About CS Diagnostics

CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1996
Employees 1
Stock Exchange OTCMKTS
Ticker Symbol CSDX
Full Company Profile

Financial Performance

Financial Statements

News

OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval

CS DIAGNOSTICS CORP. ANNOUNCES THE APPOINTMENT OF FDA CONSULTANTS Innovative tissue spacer technology for cancer radiology treatments CHEYENNE, WY / ACCESS Newswire / March 12, 2025 / CS Diagnostics C...

25 days ago - Accesswire

CS Diagnostics Corp. Announces U.S. Launch of MEDUSA

NEUSS, Germany--(BUSINESS WIRE)--CS Diagnostics Corp. Announces U.S. Launch of MEDUSA.

2 months ago - Business Wire